Articles tagged "Liver transplantation"

2019 American Transplant Congress
Early Allograft Dysfunction in High Acuity Liver Transplant Recipients
T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Organ recipient matching in Liver Transplantation (LT) has become ever-more challenging with the ongoing organ scarcity and increasing patient acuity. While the notion that…
2019 American Transplant Congress
Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease
G. Gu, Q. Xia
Renji Hospital, Shanghai, China
*Purpose: Liver transplantation has been accepted as the appropriate treatment option for pediatric metabolic liver disease and the most common methods used are LDLT and…
2019 American Transplant Congress
Peri-Operative Basiliximab is Not Associated with Post-Transplant Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
D. Salerno¹, N. Lange¹, E. Simoneau², C. Sammons³, D. Bley¹, R. S. Brown Jr⁴, J. Emond², K. Halazun⁵
¹Pharmacy, NewYork-Presbyterian Hospital, New York, NY, ²Surgery, Columbia University Irving Medical Center, New York, NY, ³Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, ⁴Medicine, Weill Cornell Medicine, New York, NY, ⁵Surgery, Weill Cornell Medicine, New York, NY
*Purpose: The optimal immunosuppression for liver transplant recipients (LTR) with hepatocellular carcinoma (HCC) is unknown. Basiliximab, an interleukin-2 receptor antagonist (IL-2RA), confers immunosuppression for LTR…
2019 American Transplant Congress
Leukopenia at the Time of Liver Transplantation: Medication Tolerance and Clinical Outcomes
E. Tiao¹, J. Casale¹, J. LaMattina², S. Hammad¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Surgery, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Leukopenia post-orthotopic liver transplant (OLT) is associated with an increased incidence of infection and mortality. Prior to OLT, leukopenia may suggest innate immunosuppression and…
2019 American Transplant Congress
Evaluating the Predictive Utility of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) for Post-Transplant Outcomes in Moderate to High-Risk Liver Transplant Candidates
P. Sheiner, S. Spence, D. Gleason, J. Riley, M. Einstein, E. UrtasunSotil, C. Rochon, B. Maneckshana, O. Serrano
Hartford Hospital, Hartford, CT
*Purpose: Previous studies suggest the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) is predictive of post-transplant outcomes in multiorgan transplant candidates. We aim to determine…
2019 American Transplant Congress
Immunization Status at the Time of Pediatric Liver Transplant: A 1-year Study through The Society of Pediatric Liver Transplantation
A. G. Feldman¹, A. Kempe², B. L. Beaty³, R. Torres¹, D. Curtis⁴, S. S. Sundaram¹
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²Pediatrics, University of Colorado, Aurora, CO, ³University of Colorado, Aurora, CO, ⁴Pediatric Infectious Diseases, University of Colorado, Aurora, CO
*Purpose: Vaccine preventable infections are a serious and common complication following transplant. Immunizations are a minimally invasive and cost-effective approach to reducing infections. The objectives…
2019 American Transplant Congress
Recipient Myeloid Notch1 Disruption Shifts Neutrophil towards Anti-Inflammatory Phenotype and Protects Liver Grafts from Ischemia-Reperfusion Injury
S. Kageyama¹, H. Hirao¹, K. Kadono¹, K. Nakamura¹, K. J. Dery¹, T. Ito², D. Oncel¹, J. Aziz¹, B. Ke¹, F. M. Kaldas², R. W. Busuttil², J. W. Kupiec‐Weglinski¹
¹Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²Surgery, Ronald Reagan UCLA Medical Center, UCLA, Los Angeles, CA
*Purpose: Liver ischemia-reperfusion injury (IRI) represents a major risk factor of early graft dysfunction and predisposes to rejection crises in orthotopic liver transplantation (OLT). We…
2019 American Transplant Congress
Histologic Ischemia Reperfusion Injury in Liver Transplantation: A Large Single Center Experience
F. M. Kaldas, T. Ito, S. Younan, J. Aziz, M. Lu, V. G. Agopian, J. DiNorcia III, H. Yersiz, D. G. Farmer, R. W. Busuttil
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Ischemia Reperfusion Injury (IRI) is known to adversely affect graft outcomes in Liver Transplantation (LT). Large series examining the significance of IRI found on…
2019 American Transplant Congress
The Impact of Sleeve Gastrectomy Following Liver Transplant in Patients with Non-Alcoholic Steatosis: A Five-Year Experience
M. C. Morris¹, A. D. Jung¹, Y. Kim¹, V. K. Dhar¹, S. Shah¹, D. Schauer², E. Smith², T. Diwan¹
¹Surgery, University of Cincinnati, Cincinnati, OH, ²Medicine, University of Cincinnati, Cincinnati, OH
*Purpose: Non-alcoholic steatohepatitis (NASH) cirrhosis is an increasingly common indication for liver transplantation (LT) in the United States and obese patients continue to be at…
2019 American Transplant Congress
MELD Score and Anti-Angiotensin Receptor Antibody Predict Long-Term Survival of Liver Re-Transplant
Q. Xu¹, A. Skaro², V. C. McAlister²
¹Pathology and Lab Medicine, London Health Science Center, London, ON, Canada, ²Surgery, London Health Science Center, London, ON, Canada
*Purpose: Recent reports indicated important while inconsistent roles of preformed donor specific antibody (DSA) to HLA in liver transplantation. Re-transplant liver patients were understudied due…